High responsiveness of HLA-B57-restricted gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection

European Journal of Immunology

Volumn 35, Issue 1, 2005, Pages 150-158

  Jansen, Christine A ^a   Kostense, Stefan ^a   Vandenberghe, Kristin ^a   Nanlohy, Nening M ^a   De Cuyper, Iris M ^a   Piriou, Erwan ^a   Manting, Erik H ^a   Miedema, Frank ^a   van Baarle, Debbie ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CTL; HIV; HLA B57

Indexed keywords

CD27 ANTIGEN; EPITOPE; GAG PROTEIN; GAMMA INTERFERON; GRANZYME B; HLA A24 ANTIGEN; HLA B57 ANTIGEN; HLA B8 ANTIGEN; PERFORIN; TETRAMER;

ALLELE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL PROTECTION; CELL SPECIFICITY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE COURSE; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MUTATION RATE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS MUTATION;

AMINO ACID SEQUENCE; ANTIGENS, CD27; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; EPITOPES; GENE PRODUCTS, GAG; GRANZYMES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HLA-A2 ANTIGEN; HLA-B ANTIGENS; HLA-B8 ANTIGEN; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MUTATION; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES;

EID: 12344334473     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425487     Document Type: Article

References (44)

1. Klein, M. R., Van Baalen, C. A., Holwerda, A. M., Kerkhof-Garde, S. R., Bende, R. J., Keet, I. P. M., Eeftinck Schattenkerk, J. K. M., Osterhaus, A. D. M. E., Schuitemaker, H. and Miedema, F., Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 1995. 181: 1365-1372.
2. + lymphocytes. Science 1999. 283: 857-860.
3. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 1999. 189: 991-998.
4. Brodie, S. J., Lewinsohn, D. A., Patterson, B. K., Jiyamapa, D., Krieger, J., Corey, L., Greenberg, P. D. and Riddell, S. R., In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 1999. 5: 34-41.
5. Allen, T. M., O'Connor, D. H., Jing, P., Dzuris, J. L., Mothe, B. R., Vogel, T. U., Dunphy, E., Liebl, M. E., Emerson, C., Wilson, N. et al., Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000. 407: 386-390.
6. Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G. S., Nowak, M. A., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A. et al., Late escape from an immumodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 1997. 3: 212-217
7. Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A. and Shaw, G. M., Antiviral pressure exerted by HIV-1 specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 1997. 3: 205-211
8. Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P. et al., Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 2001. 193: 375-386.
9. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
10. + T cell expansions: evidence for impaired CTL effector function. Eur. J. Immunol. 2001. 31: 677-686.
11. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 2000. 192: 63-76.
12. Goulder, P. J., Tang, Y., Brander, C., Betts, M. R., Altfeld, M., Annamalai, K., Trocha A, He, S., Rosenberg, E. S., Ogg, G. et al., Functionally inert hiv-specific cytotoxic t lymphocytes do not play a major role in chronically infected adults and children. J. Exp. Med. 2000. 192: 1819-1831.
13. + T cells in chronic human immunodeficiency virus infection. Blood 2000. 96: 3094-3101.
14. + T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS related non-Hodgkin lymphoma. Blood 2001. 98: 146-155.
15. + T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 2000. 165: 1082-1092.
16. + HIV-specific T cells during progression to AIDS. Blood 2002. 99: 2505-2511.
17. Keet, I. P. M., Klein, M. R., Just, J. and Kaslow, R. A., The role of host genetics in the natural history of HIV-1 infection: The needles in the haystack. AIDS 1996. 10 (Suppl. A): S59-S67.
18. Kaslow, R. A., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C. et al., Influence of combinations of human major histocompatibility complex genes in the course of HIV-1 infection. Nat. Med. 1996. 2: 405-411.
19. Altfeld, M., Addo, M. M., Rosenberg, E. S., Hecht, F. M., Lee, P. K., Vogel, M., Yu, X. G., Draenert, R., Johnston, M. N., Strick, D. et al., Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003. 17: 2581-2591.
20. Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J. and Connors, M., HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA 2000. 97: 2709-2714.
21. + memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur. J Immunol. 2000. 30: 1823-1829.
22. Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D. et al., Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 1999. 5: 677-685.
23. + T-cell selection, function and death in the primary response in vivo. J. Clin. Invest. 2000. 106: 1251-1261.
24. + T cells. J. EXP. Med. 1997. 186: 1407-1418.
25. + T cell maturation: Cd27 may provide a clue. Trends Immunol. 2002. 23: 586-591.
26. + T cells is asociated with progression to viral disease in HIV-infection. AIDS 2002. 16: 1-11.
27. Buus, S., Lauemoller, S. L., Worning, P., Kesmir, C., Frimurer, T., Corbet, S., Fomsgaard, A., Hilden, J., Holm, A. and Brunak, S., Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003. 62: 378-384.
28. Nielsen, M., Lundegaard, C., Worning, P., Lauemoller, S. L., Lamberth, K., Buus, S., Brunak, S. and Lund, O., Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 2003. 12: 1007-1017.
29. + T cell expansions: evidence for impaired T cell effector function. Eur. J. Immunol. 2001. 31: 677-686.
30. + T cells initiate IFN-gamma synthesis increases markedly over the course of infection and correlates with immunodominance. J. Immunol. 2004. 173: 456-462.
31. Resch, W., Hoffman, N. and Swanstrom, R., Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 2001. 288: 51-62.
32. + effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors. Clin. Immunol. 2004. 113: 299-309.
33. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 2002. 3: 1061-1068.
34. Gillespie, G. M., Kaul, R., Dong, T., Yang, H. B., Rostron, T., Bwayo, J. J., Kiama, P., Peto, T., Plummer, F. A., McMichael, A. J. and Rowland-Jones, S. L., Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B* 57. AIDS 2002. 16: 961-972.
35. Van der Burg, S. H., Visseren, M. J., Brandt, R. M., Kast, W. M. and Melief, C. J., Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996. 156: 3308-3314.
36. Sedlik, C., Dadaglio, G., Saron, M. F., Deriaud, E., Rojas, M., Casal, S. I. and Leclerc, C., In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J. Virol. 2000. 74: 5769-5775.
37. Derby, M., Alexander-Miller, M., Tse, R. and Berzofsky, J., High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 2001. 166: 1690-1697.
38. Franco, A., Tilly, D. A., Gramaglia, I., Croft, M., Cipolla, L., Meldal, M. and Grey, H. M., Epitope affinity for MHC class I determines helper requirement for CTL priming. Nat. Immunol. 2000. 1: 145-150.
39. + T cell responses associated with control of viremia. Science 1997. 278: 1447-1450.
40. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 1999. 5: 518-525.
41. + T cells. Eur. J. Immunol. 2002. 32: 1080-1089.
42. Molldrem, J. J., Lee, P. P., Kant, S., Wieder, E., Jiang, W., Lu, S., Wang, C. and Davis, M. M., Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J. Clin. Invest. 2003. 111: 639-647.
43. Holmberg, K., Mariathasan, S., Ohteki, T., Ohashi, P. S. and Gascoigne, N. R., TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. J. Immunol. 2003. 171: 2427-2434.
44. Dutoit, V., Rubio-Godoy, V., Doucey, M. A., Batard, P., Lienard, D., Rimoldi, D., Speiser, D., Guillaume, P., Cerottini, J. C., Romero, P. and Valmori, D., Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR. J. Immunol. 2002. 168: 1167-1171.